Loading...
XTAE
INCR
Market cap75mUSD
May 21, Last price  
565.60ILS
1D
0.86%
1Q
-7.58%
Jan 2017
123.02%
IPO
-100.00%
Name

InterCure Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
75.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
17.21%
Rev. gr., 5y
398.05%
Revenues
356m
-8.52%
13,226,90612,068,8268,469,3758,250,0425,650,0921,401,4130008,926,00065,035,000219,677,000388,684,000355,553,000
Net income
-62m
L
0-6,801,32243,441,510000265,4150-12,798,000-2,996,000-36,040,0007,296,00044,819,000-61,959,000
CFO
-54m
L
0-860,15600000-921,034-1,486,000-4,013,0007,803,00025,020,00051,267,000-53,631,000

Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
URL
https://www.intercure.co/
IPO date
Jul 26, 2007
Employees
370
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
355,553
-8.52%
388,684
76.93%
Cost of revenue
337,083
331,551
Unusual Expense (Income)
NOPBT
18,470
57,133
NOPBT Margin
5.19%
14.70%
Operating Taxes
2,248
93
Tax Rate
12.17%
0.16%
NOPAT
16,222
57,040
Net income
(61,959)
-238.24%
44,819
514.30%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
92,834
132,374
Long-term debt
128,124
150,237
Deferred revenue
Other long-term liabilities
841
1,025
Net debt
117,710
7,252
Cash flow
Cash from operating activities
(53,631)
51,267
CAPEX
(2,619)
(19,742)
Cash from investing activities
4,773
(142,497)
Cash from financing activities
(82,889)
120,446
FCF
(69,030)
(32,321)
Balance
Cash
101,326
232,794
Long term investments
1,922
42,565
Excess cash
85,470
255,925
Stockholders' equity
457,062
512,936
Invested Capital
568,110
521,737
ROIC
2.98%
12.65%
ROCE
2.83%
7.35%
EV
Common stock shares outstanding
45,573
45,353
Price
4.63
-61.66%
12.08
-41.70%
Market cap
211,047
-61.48%
547,859
-43.65%
EV
330,707
575,283
EBITDA
31,636
68,832
EV/EBITDA
10.45
8.36
Interest
24,219
14,689
Interest/NOPBT
131.13%
25.71%